Skip to content

DexCom DXCM Investing Cash Flow

Investing Cash Flow at other companies

SOL
SOLSSOLS
-$77M-97.4%
Orion Group Holdings logo
Orion Group HoldingsORN
-$9.78M-55.6%
Wabash National logo
Wabash NationalWNC
$11.41M+182%
Riverview Bancorp logo
Riverview BancorpRVSB
$116.31M
NOVA, Inc. logo
NOVA, Inc.NOV
-$50M+38.3%
Cabot Corporation logo
Cabot CorporationCBT
-$109M-55.7%

Other financials

Income statement

See full
Revenue$1.3B+13.1%
Gross profit$830.0M+20.5%
Operating income$318.3M+49.7%
Net income$249.1M+38.5%
EPS (diluted)$0.64+42.2%

Balance sheet

See full
Cash & equivalents$1.1B-4.8%
Total debt$103.3M-23.1%
Total equity$2.6B+1.9%
Total assets$6.5B-11.9%

Cash flow

See full
Operating cash flow$525.6M+186%
CapEx$76.6M-12.0%
Free cash flow$449.0M+364%

Valuation

See full
Market cap$28.88B-17.0%
Enterprise value$27.88B-17.4%
P/E28.9×-32.0×
P/S5.8×-2.3×

Profitability

See full
Gross margin62.5%+3.7pp
Operating margin22.9%+6.9pp
Net margin20.1%+6.8pp
FCF margin29.7%+15.8pp

Returns & leverage

See full
Return on equity38.5%+15.7pp
Debt / equity0.0×
Current ratio1.7×+0.2×

Where this comes from

Reported directly by DexCom in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DexCom's investing cash flow?
DexCom (DXCM) reported investing cash flow of -$298.5M in Q1 2026.
How has DexCom's investing cash flow changed year-over-year?
DexCom's investing cash flow decreased by 397.9% year-over-year, from $100.2M to -$298.5M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.